Cordis prevails again in patent spats with Medtronic, Boston
This article was originally published in Clinica
Executive Summary
Cordis's eight-year dispute with rivals Boston Scientific and Medtronic over the original Palmaz balloon expandable stent patent looks to be drawing to a close after the Johnson & Johnson company was granted its motion for final judgement. Miami, Florida-based Cordis said the US district court in Delaware will enter final judgement against Boston and Medtronic in September 30, when federal judge Sue Robinson will reinstate the damages verdicts Cordis had won in 2000. She will also award the firm pre-judgement interest based on after-tax damages. Boston's motion for a new trial was denied, although the Natick, Massachusetts firm said it will appeal this decision. Medtronic has not commented on this recent ruling.
You may also be interested in...
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Nose For A Good Tech? Philips Adds Nasal Alar Pulse Oximetry To Monitoring Portfolio
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.